Health House International Ltd (HHI)

Sydney
0.012
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.012/0.013
  • Day's Range:
    0.012 - 0.014

HHI Overview

Prev. Close
0.014
Day's Range
0.012-0.014
Revenue
16.07M
Open
0.014
52 wk Range
0.011-0.16
EPS
-0.11
Volume
0
Market Cap
2.14M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
312,031
P/E Ratio
-
Beta
-
1-Year Change
-92%
Shares Outstanding
178,224,621
Next Earnings Date
-
What is your sentiment on Health House International?
or
Market is currently closed. Voting is open during market hours.

Health House International Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Health House International Ltd Company Profile

Health House International Ltd Company Profile

Health House International Limited is an Australia-based international distributor of medicinal cannabis. Its primary activities include operations in the pharmaceutical wholesale and distribution sectors. It has two operating subsidiaries: Health House Pharma Limited, an international pharmaceutical distribution business in the United Kingdom and Health House International Pty Limited, a medicinal cannabis distribution business in Australia. Th products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is patented sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. It distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12. It also distributes products of various companies, such as Satipharm, HAPA pharm, Ananda Hemp and Little Green Pharma.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell